CACLP 2026 Returns to Xiamen with Upgraded Facilities, Richer Content, and a Broader Vision

-   New destination: return to Xiamen city after 10 years, 21–23 March 2026

-   Global scale: 45,000+ visitors & 1,350 exhibitors from 60 countries and regions in 2025

-   New highlights: integrated in-hall academic activities, noise-controlled halls, new product showcase

-   Strategic focus: AI, Primary Healthcare, Internationalization, and full-chain IVD innovation

The 23rd China International In Vitro Diagnostic Expo by CACLP and its concurrent activities will return from 21–23 March 2026, at the Xiamen International Expo Center in Fujian Province, China. This marks a significant return to South China after more than a decade. Fujian, as one of the most vibrant and open economies, serves as a gateway to the broader South China region, radiating influence across Guangdong, Guangxi, Hainan, and the Special Administrative Regions of Hong Kong and Macau.

Building on the momentum of previous editions, CACLP 2026 will feature enhanced content integration, international outreach and a forward-looking experience—designed to meet the evolving needs of the in vitro diagnostic (IVD) community.

Record Growth and Global Momentum

In 2025, CACLP achieved historic milestones: a record-breaking 45,071 professional visitors, with international attendance more than doubling—welcoming participants from over 60 countries and regions. The event brought together 1,350 exhibitors from 23 countries and regions, mainly from Asia Pacific region and Eastern Europe, making it one of the most internationally diverse editions to date. 

The exhibition featured product categories covering IVD Instruments & Reagents, Raw Materials, Components, Consumables, Lab Instrument & Equipment and Supply Chain Solutions, delivering a full-chain view of the industry.

CACLP 2025

Upgrades Venue and Visitor Experience

CACLP 2026 will span a total of 130,000 sqm with an improved, integrated layout designed to enhance navigation and engagement. The exhibition halls will be restructured into three core zones: Instruments and Reagents, Laboratory Instrument & Equipment, and Raw Material & Supply Chain, together with various onsite activities, aiming to streamline the visitor experience and better showcasing the breadth of innovations on display.

To further improve the onsite experience, the event will introduce strict sound management, dividing the exhibition halls into “silent” and active for the very first time. This thoughtful setup will create a more friendly commercial environment for business discussions while preserving the energy of live demonstrations.

CACLP 2026 Layout

Integration - Closer Collaboration, Smarter Exchange

In 2026, more than 300 top voices from academia and industry are expected to participate in venue-based sessions. For the first time, major academic and industry events, including the 11th China Experimental Medicine Conference (CEMC) and series sessions and 13th China IVD Industry Development Conference (CIIDC) and series forums, will be held within the exhibiting halls also for the very first time. This integrated setup is designed to significantly boost foot traffic and visitor engagement, while enhancing accessibility and interaction across research, industry, and application.

A dedicated AI Zone will provide an immersive showcase of smart lab tech and diagnostics, giving visitors a hands-on view of how artificial intelligence is reshaping laboratory medicine and clinical workflows.

Breakthrough - More Dynamic Ideas, Greater Visibility

CACLP’s innovation-driven features will return with expanded scope and sharper focus to spotlight the industry's most cutting-edge advances:

•   The Theater will give more visibility to disruptive technologies and emerging companies

•   New Product Showcase will reveal those first-launch products and breakthrough diagnostic solutions from the globe enterprises.

•   Onsite Activity Areas will cover themed programs on Primary Healthcare, Internationalization, and more.

CACLP continues to be a comprehensive business and academic platform for the entire IVD value chain. From upstream raw materials to downstream clinical applications, the event provides a complete, end-to-end view of the diagnostic ecosystem.

Why Xiamen: A Forward-Looking Host City

South China is one of most dynamic economic engines in China, encompassing the provinces of Guangdong, Fujian, Guangxi, and Hainan, along with the Special Administrative Regions of Hong Kong and Macau. In 2023, the region generated RMB 25.5 trillion—accounting for 20.2% of China’s GDP—and absorbed 19.5% of national foreign direct investment. 

As a key node in this powerful region, Xiamen exemplifies openness, medical readiness, and innovation. Located in the China (Fujian) Pilot Free Trade Zone (FTZ), the city contributes significantly to regional and national growth. In 2024 alone, the Xiamen FTZ accounted for 12.4% of city GDP, 35.5% of foreign trade, and 30.6% of utilized foreign capital.

The city is home to over 2,600 medical institutions, including eight Class A tertiary hospitals. Xiamen’s electronic information industry surged from ¥487 million in 1985 to ¥227.9 billion in 2024, showing extraordinary capacity for high-tech and medical industry development.

Location and Venue Overview

Enhanced Global Access and Engagement

Increased global mobility is further enhancing participation prospects. According to the National Immigration Administration, China saw 38.05 million cross-border trips in the first half of 2025, up 30.2% year-on-year, with a significant increase in visa-free entries by foreign visitors. Such developments are expected to encourage broader international presence at CACLP 2026, reinforcing its role as a truly global platform for collaboration and innovation.

As CACLP enters its 23rd year, it remains dedicated to driving innovation, accelerating international collaboration, and expanding value for the global IVD community. To explore exhibition opportunities or inquire about participation, please leave your message at: https://en.caclp.com/exhibit-reserve.html

About CACLP

With over 30 years of industry expertise, China International In Vitro Diagnostic Expo by CACLP, is well established as one of the largest exhibitions in the global in vitro diagnostic industry. Each year, it brings together more than 45,000 professionals—including entrepreneurs, scholars, users, and thought leaders from around the world—to exchange insights, foster partnerships, and collectively shape the future of IVD.

The event covers the entire diagnostics value chain from upstream to downstream, offering a comprehensive showcase of products, technologies, and services. Alongside a great number of high-level academic and educational programs held concurrently onsite, and year-round promotional solutions, CACLP continues to serve as a vital platform for global IVD players.

About GL events

Founded in Lyon in 1978, GL events is world-class leading provider of integrated solutions and services for events operating. GL events’ business covers more than 20 countries across five continents, with over 90 branches and more than 6,000 employees. GL events is listed on the Euronext Paris Segment B in 1998.

Through the unique business model – a complementary mix of products and services addressing the needs of all events and customer expectations.

·  LIVE: provide comprehensive solutions from design to deliver events, 6,000 events served annually.

·  VENUES: provide venues layout and operation, venues management, technical support, and more customized services, more than 60 venues under management.

·  EXHIBITIONS: plan and organize tradeshows to bring together B2B & B2C communities, with 480 proprietary exhibitions.